NDC 71287-119

YESCARTA

Axicabtagene Ciloleucel

YESCARTA is a Intravenous Suspension in the Cellular Therapy category. It is labeled and distributed by Kite Pharma, Inc.. The primary component is Axicabtagene Ciloleucel.

• Product ID: 71287-119_17f11ba2-5241-4e01-af69-6b4ea9ba4234
• NDC: 71287-119
• Product Type: Cellular Therapy
• Proprietary Name: YESCARTA
• Generic Name: Axicabtagene Ciloleucel
• Dosage Form: Suspension
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2017-10-18
• Marketing Category: BLA / BLA
• Application Number: BLA125643
• Labeler Name: Kite Pharma, Inc.
• Substance Name: AXICABTAGENE CILOLEUCEL
• Active Ingredient Strength: 2000000 1/68mL
• Pharm Classes: CD19-directed Chimeric Antigen Receptor [EPC],Genetically-modified Autologous T Cells [EPC],CD19 Receptor Interactions [MoA],T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 71287-119-02

1 BAG in 1 PACKAGE (71287-119-02) > 68 mL in 1 BAG (71287-119-01)

• Marketing Start Date: 2017-10-18
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 71287-119-02 [71287011902]

YESCARTA SUSPENSION

• Marketing Category: BLA
• Application Number: BLA125643
• Product Type: CELLULAR THERAPY
• Billing Unit: EA
• Marketing Start Date: 2017-10-18

NDC 71287-119-01 [71287011901]

YESCARTA SUSPENSION

• Marketing Category: BLA
• Application Number: BLA125643
• Product Type: CELLULAR THERAPY
• Billing Unit: EA
• Marketing Start Date: 2017-10-18

Drug Details

Active Ingredients

Ingredient	Strength
AXICABTAGENE CILOLEUCEL	2000000 1/68mL